GenScript Biotech announces Legend Biotech Form 6-K for Q2 ended June 30, 2026
LEGN•Legend Biotech files second-quarter Form 6-K
GenScript Biotech announced the posting of Legend Biotech’s Form 6-K covering financial results for the second quarter ended June 30, 2026.
Report filed with the SEC on Aug. 11, 2026: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000022/0001801198-26-000022-index.html.
